PPBT

Purple Biotech
PPBT

Overview Fund Trends Analyst Outlook Journalist POV

10 hedge funds and large institutions have $157K invested in Purple Biotech in 2018 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding

Funds holding: →

more ownership

Funds ownership: →

less capital invested

Capital invested by funds: $ → $

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

Holders
10
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$41.5K
2
+$26K
3
+$15K
4
TSS
Two Sigma Securities
New York
+$12K
5
UBS Group
UBS Group
Switzerland
+$1.2K

Top Sellers

1
-$20.7K
2
-$4.55K
3
-$286
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$63K
2
$26K
3
$16K
4
$15K
5
$13K
6
$12K
7
$7K
8
$2K
9
$2K
10
$1K